2017
DOI: 10.1016/j.jdiacomp.2017.04.013
|View full text |Cite
|
Sign up to set email alerts
|

Serum RBP4 and CKD: Association with insulin resistance and lipids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
9
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 38 publications
1
9
0
Order By: Relevance
“…5c ; P ≤ 0.05). Interestingly, APLN is a known adipokine implicated in coagulation, insulin resistance and diabetes [ 49 ] and its higher expression in layers is consistent with the pattern of another pro-inflammatory adipokine in mammal, RBP4 [ 50 ] .…”
Section: Resultsmentioning
confidence: 81%
“…5c ; P ≤ 0.05). Interestingly, APLN is a known adipokine implicated in coagulation, insulin resistance and diabetes [ 49 ] and its higher expression in layers is consistent with the pattern of another pro-inflammatory adipokine in mammal, RBP4 [ 50 ] .…”
Section: Resultsmentioning
confidence: 81%
“…However, our study reported that both of those biomarkers had excellent clinical accuracy for eGFR decline prediction. Several previous studies also reported elevated serum RBP4 levels in kidney disease[ 12 13 23 24 ] but did not make a comparison between those two biomarkers.…”
Section: Discussionmentioning
confidence: 98%
“…was a community‐based study composed of both CHF patients and subjects with normal cardiac function. Another potential confounder might be renal function since RBP4 is mainly excreted by the kidney . Indeed, eGFR was lower in patients with high concentration of RBP4 in our study, indicating increased circulating RBP4 may serve as a biomarker for renal dysfunction in patients with CHF.…”
Section: Discussionmentioning
confidence: 56%